Castellano, D., Bajetta, E., Panneerselvam, A., Saletan, S., Kocha, W., O'Dorisio, T., . . . Hobday, T. (2013). Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study. AlphaMed Press.
Citación estilo ChicagoCastellano, Daniel, Emilio Bajetta, Ashok Panneerselvam, Stephen Saletan, Walter Kocha, Thomas O'Dorisio, Lowell B. Anthony, y Timothy Hobday. Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study. AlphaMed Press, 2013.
Cita MLACastellano, Daniel, et al. Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study. AlphaMed Press, 2013.